Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
acute kidney injury 1 nephrologydiseases
chronic kidney disease 3 nephrologydiseases

There are not enough annotations found in this document to create the proximity graph.


Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
acute kidney injury 39109 important role in treating many disorders resulting from ischemia–reperfusion injury, including ischemic acute kidney injury , myocardial injury, and damage to transplanted organs. Furthermore, through effects on transient receptor
chronic kidney disease 730 pharmacologically manipulate HIF may provide new and exciting possibilities in the treatment of anemia of chronic kidney disease (CKD) as well as in multiple other disease states involving ischemia–reperfusion injury. This article
chronic kidney disease 1957 improve outcomes at higher hemoglobin targets.1. IntroductionAnemia is a common feature in patients with chronic kidney disease (CKD). Although optimal treatment of this condition remains controversial, for many years, erythropoiesis-stimulating
chronic kidney disease 32540 to pharmacologically manipulate HIF present exciting new possibilities in the treatment of anemia of chronic kidney disease .”3.4. Clinical Impact of HIF-PHIs in Anemia of CKDThe chief concerns surrounding the current therapeutic

You must be authorized to submit a review.